Cargando…
Chemoradiation provides a physiological selective pressure that increases the expansion of aberrant TP53 tumor variants in residual rectal cancerous regions
Neoadjuvant chemoradiotherapy has been introduced in patients with surgically resected rectal cancer and reduced the local recurrence. Heterogeneity exists in rectal cancer, and we hypothesized that there are subclones resistant to chemoradiotherapy within the cancer mass. We performed DNA-targeted...
Autores principales: | Sakai, Kazuko, Kazama, Shinsuke, Nagai, Yuzo, Murono, Koji, Tanaka, Toshiaki, Ishihara, Soichiro, Sunami, Eiji, Tomida, Shuta, Nishio, Kazuto, Watanabe, Toshiaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4259426/ https://www.ncbi.nlm.nih.gov/pubmed/25275295 |
Ejemplares similares
-
Immunohistochemical detection of high-mobility group box 1 correlates with resistance of preoperative chemoradiotherapy for lower rectal cancer: a retrospective study
por: Hongo, Kumiko, et al.
Publicado: (2015) -
Analysis of anastomotic leakage after rectal surgery: A case-control study
por: Tanaka, Junichiro, et al.
Publicado: (2015) -
Delayed abdominal wall abscess after abdomino-perineal resection simulating local recurrence of rectal cancer
por: Kawai, Kazushige, et al.
Publicado: (2014) -
Leucine-rich repeat-containing G protein-coupled receptor 5 and CD133 expression is associated with tumor progression and resistance to preoperative chemoradiotherapy in low rectal cancer
por: Harada, Yuzo, et al.
Publicado: (2017) -
Alpha-fetoprotein-producing early rectal carcinoma: a rare case report and review
por: Anzai, Hiroyuki, et al.
Publicado: (2015)